A meta-analysis showed that Oct-3/4 expression in lung cancer was associated with poor outcomes concerning the differentiation degree, the TNM Classification of Malignant Tumors (TNM) and lymphatic metastasis (136). The gene discussed is POU5F1; the disease is lung cancer.